Chartwell Investment Partners LLC Takes Position in IBM (IBM)

Chartwell Investment Partners LLC purchased a new stake in shares of IBM (NYSE:IBM) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 79,680 shares of the technology company’s stock, valued at approximately $12,225,000.

Other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. raised its position in shares of IBM by 3.7% during the 2nd quarter. Vanguard Group Inc. now owns 62,228,040 shares of the technology company’s stock worth $9,572,538,000 after purchasing an additional 2,241,818 shares during the last quarter. Nordea Investment Management AB raised its position in shares of IBM by 151.2% during the 2nd quarter. Nordea Investment Management AB now owns 3,250,047 shares of the technology company’s stock worth $499,955,000 after purchasing an additional 1,956,033 shares during the last quarter. Janus Henderson Group PLC raised its position in shares of IBM by 1,155.3% during the 2nd quarter. Janus Henderson Group PLC now owns 1,358,103 shares of the technology company’s stock worth $208,923,000 after purchasing an additional 1,249,916 shares during the last quarter. BlackRock Inc. raised its position in shares of IBM by 2.4% during the 2nd quarter. BlackRock Inc. now owns 52,936,360 shares of the technology company’s stock worth $8,143,204,000 after purchasing an additional 1,241,441 shares during the last quarter. Finally, Stifel Financial Corp raised its position in shares of IBM by 9,678.2% during the 3rd quarter. Stifel Financial Corp now owns 815,897 shares of the technology company’s stock worth $118,347,000 after purchasing an additional 807,553 shares during the last quarter. Institutional investors own 57.02% of the company’s stock.

How to Become a New Pot Stock Millionaire

Shares of NYSE IBM opened at $150.57 on Friday. IBM has a 52-week low of $139.13 and a 52-week high of $172.93. The firm has a market cap of $141,970.39, a PE ratio of 10.91, a P/E/G ratio of 2.25 and a beta of 0.90. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.33 and a quick ratio of 1.29.

IBM (NYSE:IBM) last announced its quarterly earnings data on Thursday, January 18th. The technology company reported $5.18 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $5.17 by $0.01. IBM had a net margin of 7.27% and a return on equity of 69.48%. The company had revenue of $22.54 billion during the quarter, compared to analysts’ expectations of $22.03 billion. During the same period in the previous year, the company earned $5.01 EPS. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. sell-side analysts expect that IBM will post 13.82 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Saturday, March 10th. Stockholders of record on Friday, February 9th were paid a dividend of $1.50 per share. The ex-dividend date was Thursday, February 8th. This represents a $6.00 annualized dividend and a dividend yield of 3.98%. IBM’s dividend payout ratio is presently 43.48%.

In related news, insider Diane J. Gherson sold 5,000 shares of the company’s stock in a transaction on Monday, February 26th. The shares were sold at an average price of $156.00, for a total transaction of $780,000.00. Following the completion of the sale, the insider now directly owns 20,581 shares of the company’s stock, valued at approximately $3,210,636. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Frederick H. Waddell purchased 610 shares of the firm’s stock in a transaction that occurred on Wednesday, January 31st. The shares were acquired at an average cost of $163.38 per share, with a total value of $99,661.80. The disclosure for this purchase can be found here. 0.17% of the stock is owned by insiders.

IBM has been the subject of several research reports. Societe Generale set a $149.00 price objective on IBM and gave the stock a “sell” rating in a research report on Friday, January 19th. Barclays upgraded IBM from an “underweight” rating to an “overweight” rating and lifted their price objective for the stock from $133.00 to $192.00 in a research report on Wednesday, January 17th. Cantor Fitzgerald restated a “hold” rating and set a $152.00 price objective on shares of IBM in a research report on Friday, January 19th. Vetr downgraded IBM from a “strong-buy” rating to a “buy” rating and set a $173.45 price objective for the company. in a research report on Tuesday, December 12th. Finally, Morgan Stanley cut shares of IBM from an “equal weight” rating to an “underweight” rating and lifted their target price for the stock from $200.00 to $205.00 in a research note on Tuesday, January 23rd. Six research analysts have rated the stock with a sell rating, seventeen have issued a hold rating and eleven have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $166.01.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/04/07/chartwell-investment-partners-llc-takes-position-in-ibm-ibm.html.

IBM Company Profile

International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers Watson, a cognitive computing platform that interacts in natural language, processes big data, and learns from interactions with people and computers.

Want to see what other hedge funds are holding IBM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IBM (NYSE:IBM).

Institutional Ownership by Quarter for IBM (NYSE:IBM)

Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply